Bradsaude (BSP:SAUD3) ROCE %: 62.55% (As of Mar. 2026)

What is Bradsaude ROCE %?

Bradsaude BSP:SAUD3 +2.00% 94 ROCE % is 62.55% as of Mar. 2026. GuruFocus rates BSP:SAUD3 with a GF Score™ of 94/100 and a GF Value™ of R$13.48 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bradsaude's annualized ROCE % for the quarter that ended in Mar. 2026 was 62.55%.

Bradsaude (BSP:SAUD3) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bradsaude ROCE % Related Terms

Bradsaude ROCE % Historical Data

* Premium members only.

The historical data trend for Bradsaude's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bradsaude ROCE % Chart

Bradsaude Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

36.44

42.68

54.90

55.68

63.27

Bradsaude Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															71.98	60.25	60.14	51.14	62.55

94GF Score

Bradsaude SA BSP:SAUD3

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bradsaude ROCE % Calculation

Bradsaude's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	872.249	/	( ( (2122.069 - 764.626)	+	(1948.841 - 549.169) )	/ 2 )
	=	872.249	/	( (1357.443	+	1399.672)	/ 2 )
	=	872.249	/	1378.5575
	=	63.27 %

Bradsaude's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	923.436	/	( ( (1948.841 - 549.169)	+	(2124.662 - 571.539) )	/ 2 )
	=	923.436	/	( ( 1399.672	+	1553.123 )	/ 2 )
	=	923.436	/	1476.3975
	=	62.55 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 62.55% mean?

Bradsaude (BSP:SAUD3) has a ROCE % of 62.55% as of Mar. 2026.

Is Bradsaude's ROCE % too high?

Bradsaude's current ROCE % is 62.55%. The Healthcare Plans industry median ROCE % is 9.38. Bradsaude's value of 62.55% is 566.8% above this industry median. Overall, Bradsaude has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Bradsaude's ROCE % compare to UNH and CVS?

Bradsaude's ROCE % of 62.55% can be compared against companies in the Healthcare Plans industry. The industry median ROCE % is 9.38. Bradsaude's value of 62.55% is 566.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Plans company?

The median ROCE % among Healthcare Plans companies is 9.38, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bradsaude's current ROCE % of 62.55% is 566.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median ROCE % is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bradsaude's current ROCE % is 62.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bradsaude stock overvalued right now?

Based on GuruFocus' analysis, Bradsaude (BSP:SAUD3) is currently considered Fairly Valued. The stock's GF Value™ is R$13.48, compared to a current price of R$14.28 — trading 5.9% above its estimated fair value. The current ROCE % is 62.55% and 566.8% above the Healthcare Plans industry median of 9.38. Bradsaude's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Bradsaude (BSP:SAUD3), the current ROCE % is 62.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bradsaude (BSP:SAUD3) Overvalued in 2026?

Based on GuruFocus' analysis, Bradsaude stock appears to be overvalued. The current stock price of R$14.28 is trading 5.9% above its estimated GF Value™ of R$13.48. GuruFocus considers Bradsaude to be Fairly Valued.

Key valuation signals for BSP:SAUD3:

ROCE %: 62.55%
GF Value™: R$13.48 vs. price of R$14.28 (5.9% above fair value)
GF Score™: 94/100 with 6 warning signs
Industry Position: 566.8% above the Healthcare Plans median

No single metric tells the full story. See the BSP:SAUD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bradsaude Business Description

Industry Healthcare Healthcare Plans

Comparable Companies BSP:QUAL3 UNH CVS ELV CI HUM CNC MOH OSCR ALHC CLOV PGNY SZSE:000503 NSE:MEDIASSIST BJSE:920656 ROCO:6665 PFHO

Address Alameda Araguaia, 2104, 21 andar, Alphaville, Barueri, SP, BRA, 06460-040

Website https://www.saud3.com.br

Bradsaude SA operates a healthcare ecosystem in Brazil formed through the consolidation of companies across different healthcare segments. Its operations include health and dental insurance, hospitals, primary care clinics, healthcare technology, diagnostics, and oncology services. The company serves more than 13 million beneficiaries and operates a healthcare network that includes approximately 4,000 hospital beds across the country.

94GF Score

Get the complete analysis for BSP:SAUD3

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$14.28

Price

R$13.48

GF Value

View BSP:SAUD3 Analysis

See ROCE % data for all stocks →